Xu Hockin H K, Weir Michael D, Simon Carl G
Department of Endodontics, Prosthodontics and Operative Dentistry, University of Maryland Dental School, Baltimore, MD 21201-1586, USA.
Dent Mater. 2008 Sep;24(9):1212-22. doi: 10.1016/j.dental.2008.02.001. Epub 2008 Mar 21.
Seven million people suffer bone fractures each year in the U.S., and musculoskeletal conditions cost $215 billion/year. The objectives of this study were to develop moldable/injectable, mechanically strong and in situ-hardening calcium phosphate cement (CPC) composite scaffolds for bone regeneration and delivery of osteogenic cells and growth factors.
Tetracalcium phosphate [TTCP: Ca(4)(PO(4))(2)O] and dicalcium phosphate (DCPA: CaHPO(4)) were used to fabricate self-setting calcium phosphate cement. Strong and macroporous scaffolds were developed via absorbable fibers, biopolymer chitosan, and mannitol porogen. Following established protocols, MC3T3-E1 osteoblast-like cells (Riken, Hirosaka, Japan) were cultured on the specimens and inside the CPC composite paste carrier.
The scaffold strength was more than doubled via reinforcement (p<0.05). Relationships and predictive models were established between matrix properties, fibers, porosity, and overall composite properties. The cement injectability was increased from about 60% to nearly 100%. Cell attachment and proliferation on the new composite matched those of biocompatible controls. Cells were able to infiltrate into the macropores and anchor to the bone mineral-like nano-apatite crystals. For cell delivery, alginate hydrogel beads protected cells during cement mixing and setting, yielding cell viability measured via the Wst-1 assay that matched the control without CPC (p>0.1). For growth factor delivery, CPC powder:liquid ratio and chitosan content provided the means to tailor the rate of protein release from CPC carrier.
New CPC scaffolds were developed that were strong, tough, macroporous and osteoconductive. They showed promise for injection in minimally invasive surgeries, and in delivering osteogenic cells and osteoinductive growth factors to promote bone regeneration. Potential applications include various dental, craniofacial, and orthopedic reconstructions.
在美国,每年有700万人遭受骨折,肌肉骨骼疾病每年花费2150亿美元。本研究的目的是开发可塑形/可注射、机械强度高且能原位硬化的磷酸钙骨水泥(CPC)复合支架,用于骨再生以及成骨细胞和生长因子的递送。
使用磷酸四钙[TTCP:Ca(4)(PO(4))(2)O]和磷酸二钙(DCPA:CaHPO(4))制备自固化磷酸钙骨水泥。通过可吸收纤维、生物聚合物壳聚糖和甘露醇致孔剂制备出坚固且具有大孔结构的支架。按照既定方案,将MC3T3-E1成骨样细胞(日本广岛理研)培养在标本上以及CPC复合糊剂载体内部。
通过增强作用,支架强度增加了一倍多(p<0.05)。在基质特性、纤维、孔隙率和整体复合材料特性之间建立了关系和预测模型。骨水泥的可注射性从约60%提高到了近100%。新复合材料上的细胞附着和增殖情况与生物相容性对照相当。细胞能够渗入大孔并锚定在骨矿物质样纳米磷灰石晶体上。对于细胞递送,藻酸盐水凝胶珠在骨水泥混合和凝固过程中保护细胞,通过Wst-1检测法测得的细胞活力与不含CPC的对照相当(p>0.1)。对于生长因子递送,CPC粉末与液体的比例和壳聚糖含量提供了调整蛋白质从CPC载体释放速率的方法。
开发出了新型CPC支架,其坚固、坚韧、具有大孔结构且具有骨传导性。它们有望用于微创手术注射,以及递送成骨细胞和骨诱导生长因子以促进骨再生。潜在应用包括各种牙科、颅面和骨科重建。